Dr. Nikhil Bharti
Scientific Co-Founder & Director · CSO / CTO
Molecular biologist focused on translation regulation and tRNA biology. Leads scientific strategy, platform architecture and experimental-validation planning.
THE PEOPLE BEHIND THE PURPOSE
Scientific leadership.
Shared founding responsibility.
KritRNA is led by two equal co-founders and directors. Dr. Nikhil Bharti leads scientific and technology development. Pragati Bhaisora leads outreach, awareness, stakeholder communication and community engagement.
Read the founding story ↗
Pragati Bhaisora
Co-Founder & Director · Outreach & Awareness Strategist
Leads rare-disease outreach, awareness, stakeholder communication and patient-community engagement, with equal co-founder responsibility for building KritRNA.
EXTENDED NETWORK
Building capability around the founders.
The developing build and advisory network is shown with its current recorded status. Pending discussions are not confirmed appointments or institutional partnerships.
Additional AI / ML developer
Computational-development role currently under discussion; appointment not yet announced.
Sandeep M. Eswarappa
Scientific-advisor onboarding and paperwork underway.
Additional scientific advisors
Approached; names will be announced only after formal confirmation.
LNJP Hospital — Genetics Department
Clinical-advisory discussions initiated; individual clinicians will be named after formal confirmation.
THE ACADEMIC FOUNDATION
Founder research record.
Published research is part of our scientific foundation. It is distinct from the developing company platform and from evidence generated for a KritRNA candidate.
Nature Communications · 2024 · Co-first author
Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations
Nikhil Bharti and Leonardo Santos contributed equally. This published academic work is a scientific foundation, not validation of KritRNA’s developing platform.
Nature · 2023 · Co-author
Engineered tRNAs suppress nonsense mutations in cells and in vivo
Peer-reviewed study of engineered suppressor tRNAs in cellular and in-vivo models.
Journal of Biological Chemistry · 2023 · Co-author
tRNA biology and translation regulation
Co-authored work in tRNA biology and translational regulation. Full bibliographic details are being cross-checked before final publication.
Former research institutions are not represented as current company affiliates or endorsers. A publication record does not establish company ownership of university intellectual property.